We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Mobile Diabetes Tools Improve Glycemic Control

By HospiMedica International staff writers
Posted on 05 Mar 2020
Patients with type 2 diabetes (T2D) who use mobile devices to access diabetes management portals were more adherent and had improved glycated hemoglobin A1c (HbA1c) levels, according to a new study.

Researchers at Emory University (Atlanta, GA, USA), Kaiser Permanente Northern California (Oakland, USA), Harvard Medical School (HMS; Boston, MA, USA), and other institutions conducted a retrospective study involving 111,463 Kaiser Permanente patients with diabetes (who also serving as their own controls) in order to examine the effect of adding mobile patient portal access on medication adherence and glycemic levels. More...
Access status was categorized as never used, used from a computer only, used from a mobile device only, or used from both computer and mobile device.

Patients could register online for free access, which allowed them to get general health information, see test results, securely send and receive messages to and from their healthcare providers, make medical appointments, and request prescription refills. The main outcomes and measures were medication adherence, as measured by monthly percentage of days covered (PDC); and glycemic levels, a measured by changes in HbA1c levels. The results showed that the number of patients using the portal from both a computer and mobile device increased over time from 34.42% in April 2015 to 61.71% in December 2017.

Among those with no prior portal access, adding computer-only portal access was associated with an increase in PDC of 1.16% and a change of −6% in HbA1c level. Adding both mobile and computer portal access was associated with an increase in PDC of 1.67% and a change of −13% in HbA1c level. Among those patients with baseline HbA1c level higher than 8%, changing from no portal access to both computer and mobile access was associated with an increase in PDC of 5.09% and a change of −19% in HbA1c level. The study was published on February 19, 2020, in JAMA Network Open.

“This is an example of how the healthcare system, by offering patients access to their own information and the ability to manage their healthcare online, can improve their health. Offering this in a mobile-friendly way can give even more patients the ability to engage with their healthcare,” said senior author Mary Reed, PhD, of the Kaiser Permanente Division of Research. “Patients can use technology to better manage their own care, their medications, and their diabetes. It literally puts the access to these tools in the patient's own pocket wherever they go.”

Related Links:
Emory University
Kaiser Permanente Northern California
Harvard Medical School



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.